Tag: Lorlatinib

Pfizer lung cancer drug Lorbrena bags US FDA approval

pharmanewsdaily- November 3, 2018

Lorbrena FDA approval : US pharma giant Pfizer has bagged approval from the US Food and Drug Administration (FDA) for Lorbrena (lorlatinib) for anaplastic lymphoma ... Read More